AVNS Q3 2023 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$171M-0.6% YoY

Gross Profit

$96M55.8% margin

Operating Income

$26M14.9% margin

Net Income

-$4M-2.2% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+1.1%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$25M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$503M

Stockholders' Equity

$1.2B

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$171M	$172M	-0.6%
Gross Profit	$96M	$100M	-4.7%
Operating Income	$26M	$15M	+70.0%
Net Income	-$4M	$16M	-123.6%

Revenue Segments

Digestive Health

$95M69%

Interventional pain

$42M31%